Related Experiment Video
Updated: Aug 18, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure
Samhita Panda1, K Radhakrishnan
1R Madhavan Nayar Center for Comprehensive Epilepsy Care, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala.
Abstract:
We report two children with localization related epilepsies, who presented with somnolence, seizure exacerbation, behavioral alteration, decline in speech and cognitive abilities, and ataxia while being treated with a combination of valproate and topiramate, but had previously tolerated valproate with other antiepileptic drugs. These children had elevated serum ammonia, normal transaminase levels, and generalized slowing of EEG background activity during encephalopathy, which promptly reverted back to normal along with clinical improvement following withdrawal of valproate. To our knowledge, this is the first documentation of valproate-induced hyperammonemic encephalopathy enhanced by topiramate from India. We intend to alert internists, pediatricians, psychiatrists and neurologists about this underrecognized adverse effect of antiepileptic drug polytherapy.
Related Concept Videos
Hepatic Encephalopathy
Antiepileptic Drugs: Glutamate Antagonists
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Potential Scenarios
Encephalitis l: Introduction
Drug Toxicity: Overview